At the beginning of the new year, there is a constant stream of good news

The first good news of 2024 is coming

Fubio Biotechnology has been awarded the high-tech enterprise certification

The recognition of high-tech enterprises refers to the recognition of enterprises that continuously conduct research and development and transform technological achievements in the high-tech fields supported by the state, form core independent intellectual property rights, and carry out business activities based on this, aiming to cultivate and create new technologies and new business models, and promote economic upgrading and development. During the identification process, multiple conditions such as intellectual property rights, high-tech products or services, number of scientific and technological personnel, and innovation capabilities of the enterprise will be strictly examined.

The successful recognition of high-tech enterprises this time marks significant achievements of Fubio Biotechnology in research and development, innovation capabilities, and achievement transformation. Fubio Biotechnology will take this as an opportunity to solidly and steadily play the leading role of high-tech enterprises, focusing on the development path of continuous innovation, and continuously making efforts in professional directions such as technological innovation, management innovation, and service innovation, providing higher quality products and more professional services for society, customers, and partners, and making greater contributions to the development of the industry.

Fubio Biotechnology  Co., Ltd. is a high-tech enterprise located in Suzhou Industrial Park, focusing on gene technology research and application transformation. The company is committed to the research and development of virus products and services, with the most comprehensive and diverse virus vector library in China. Its customer base covers fields such as life science research, in vitro diagnostics, vaccine development, and cell gene therapy. We can provide full process services and technical support from project initiation research, scheme design, virus preparation to production process development to meet the product needs of different viruses in the research and development process of cell gene therapy and in vitro diagnostics enterprises.